Navigation Links
GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
Date:10/8/2007

- Innovative approach to developing anti-infective medicines provides hope

for combating problems of resistance -

PALO ALTO, Calif. and LONDON, Oct. 8 /PRNewswire/ -- Anacor Pharmaceuticals and GlaxoSmithKline today announced that they have entered into a worldwide strategic alliance for the discovery, development and commercialization of novel medicines for viral and bacterial diseases. The collaboration provides GlaxoSmithKline access to Anacor's proprietary boron-based chemistry for use against selected targets.

GlaxoSmithKline will participate in the alliance through its Infectious Diseases Centre of Excellence for Drug Discovery (ID CEDD). Under the terms of the agreement, Anacor will grant GlaxoSmithKline options to select product candidates developed under the collaboration that are directed to up to four discovery targets and with the potential for at least eight product options. Anacor will primarily be responsible for the discovery and development of boron-containing small molecule drug candidates through clinical proof of concept, at which point GlaxoSmithKline will have an exclusive option to license each compound for further development and commercialization on a worldwide basis. Anacor will have the right to further develop and commercialize compounds for which GlaxoSmithKline does not exercise its option. Anacor will receive a $12 million upfront payment and a $10 million equity financing commitment from GlaxoSmithKline. Contingent on achieving certain milestones, Anacor is eligible to receive discovery, development, regulatory and commercial milestones ranging up to $252 million and $331 million for each product candidate. If GlaxoSmithKline exercises its option at the proof of concept stage, Anacor will receive tiered double digit royalties, which are dependent on sales achieved.

Boron has been a relatively underutilized element in pharmaceutical products, in part due to a lack of naturally occurring boron
'/>"/>

SOURCE Anacor Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. GenTel acquires GlaxoSmithKline chip platform
2. Deltanoid Pharmaceuticals begins phase II osteoporosis study
3. The Coming of Biotech Generic Pharmaceuticals
4. Biomedical Alliance about more than stem cells
5. Doyle seeks $2.5M for biomedical alliance
6. Alliance looks to create the right chemistry in SE Wisconsin
7. Biomedical alliance marks first full year
8. New alliance to provide Wi-Fi network for City of Madison
9. Budget axe could cut SE Wisconsin tech alliance funding
10. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
11. Milwaukee research alliance sees need for incubator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual list ... as number 1,361 in growth for the three years through 2014. Being named to ... privately held organizations in the country. , “We are thrilled to make the ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... presented new data on the relationship of genetics and hypertension at the ... Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts an extensive ...
(Date:8/26/2015)... -- Roka Bioscience, Inc. (NASDAQ: ROKA ), a molecular ... the detection of foodborne pathogens, today announced that Paul ... Company Emerging Growth Conference on September 2 at 9:20am ... York Marriott Marquis. A live webcast ... relations section of Roka Bioscience,s website at http://rokabio.investorroom.com/ ...
(Date:8/26/2015)...  Platform therapeutic company Symic Biomedical, Inc. ("Symic") ... Phase II SBIR grant from the National Institutes ... agent to reduce arteriovenous fistula (AVF) failures, a ... disease (ESRD) patients undergoing hemodialysis. The two-year project, ... Digestive and Kidney Diseases (NIDDK), will allow Symic ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
... FRANCISCO, Oct. 31 BioSpace, BioNJ, and,Pennsylvania Bio ... the Biotech 2007 Life Science Career Fair on ... held in conjunction with the Biotech 2007 Symposium,generated ... diagnostics candidates which kept the companies that were,recruiting ...
... BASINGSTOKE, England, October 31 The Board of,Directors ... SHQ), the global,specialty biopharmaceutical company, announces today that ... Executive Director with immediate effect. Mr Mott ... Inc, a,role he was appointed to in 2000. ...
... Calif., Oct. 31 BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: ... Officer of BioMarin, will present a,company update at the ... City on Wednesday, November 7, 2007 at 12:40 p.m. ... webcast of the presentation,via the investor section of the ...
Cached Biology Technology:BioSpace, BioNJ and Pennsylvania Bio Welcome Over 800 Life Science Career Candidates to Biotech 2007 Career Fair 2David Mott Appointed Non Executive Director at Shire 2David Mott Appointed Non Executive Director at Shire 3
(Date:8/24/2015)... Calif. , Aug. 24, 2015  Based on its ... recognizes DERMALOG with the 2015 African Biometrics Company of the ... has achieved substantial commercial success in Africa ... , where it has implemented one of the largest ... banks as well as the Central Bank of ...
(Date:8/19/2015)... N.Y. , Aug. 19, 2015  VOXX ... that it has entered into a Definitive Agreement ... property, of iris authentication market leader EyeLock through ... VOXX will have a controlling interest in the ... subject to completion of due diligence.  Expanding on ...
(Date:8/12/2015)... Minn. , Aug. 12, 2015   MedNet ... supports the entire spectrum of clinical research, is proud ... , the company,s comprehensive SaaS-based eClinical technology platform, has ... during the first two quarters of 2015.   Q2 ... second largest quarters measured by contract value sold in ...
Breaking Biology News(10 mins):Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 5Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 6VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5MedNet Solutions Experiences Explosive Corporate Growth 2
... always easy. In many parts of the world summers ... those with intricate cooling systems. In cooler climates where ... are still challenging for producers who need to fulfill ... predicting greenhouse tomato yields is at the forefront of ...
... NOVA SCOTIAIrish potato, one of the world,s major food ... various products; consider the popularity of consumer favorites like ... food production industry, products are accepted or rejected on ... Quality defects such as after-cooking darkening, or ACDa change ...
... , KAUNAS, LITHUNIASearching for ways to improve the ... have found success with new technology that features ... illuminator. The technology, which can be applied in ... found to decrease concentrations of harmful nitrates while ...
Cached Biology News:Demystifying yield fluctuations for greenhouse tomatoes 2It's elemental: Potato after-cooking darkening may be affected by nutrients 2Solid-state illuminator reduces nitrates in leafy green vegetables 2
... clear, APET plastic tray. Ideal for staining ... trays used for multipurposes. Pour spouts in ... marker or label may be used for ... on rockers or shakers for staining several ...
ID clarifier: non-treated with lid...
... fast and reliable scalable automation for today's drug discovery ... are available in three base configurations; Mini Workstation Series, ... ... All Staccato Application Series systems use a ...
... Systems provide fast and reliable automation ... and drug development laboratories. Staccato Custom ... specifications, providing solutions that are tailored ... Custom Systems are controlled with either ...
Biology Products: